These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34990768)

  • 1. Network pharmacology analysis and experimental validation to explore the mechanism of Shenlian extract on myocardial ischemia.
    Li JJ; Wang CM; Wang YJ; Yang Q; Cai WY; Li YJ; Song M; Zang YL; Cui XH; Li Q; Chen Y; Weng XG; Zhu XX
    J Ethnopharmacol; 2022 Apr; 288():114973. PubMed ID: 34990768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated serum pharmacochemistry with network pharmacology and pharmacological validation to elucidate the mechanism of yiqitongmai decoction (YQTMD) against myocardial infarction.
    Yu H; Wang N; Zhao X; Han L; Peng J
    J Ethnopharmacol; 2024 Sep; 331():118329. PubMed ID: 38750989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenlian extract attenuates myocardial ischaemia-reperfusion injury via inhibiting M1 macrophage polarization by silencing
    Song M; Cui X; Zhang J; Li Y; Li J; Zang Y; Li Q; Yang Q; Chen Y; Cai W; Weng X; Wang Y; Zhu X
    Pharm Biol; 2022 Dec; 60(1):2011-2024. PubMed ID: 36239618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic exploration of the shenlian formula in the suppression of atherosclerosis progression via network pharmacology and in vivo experimental validation.
    Xing-Xing C; Ri-Jin H; Xin-Ge W; Cai-Ying Y; Qing Y; Ying C; Qi L; Xiao-Xin Z; Lihong Y; Long C; Yu D
    J Ethnopharmacol; 2024 Oct; 333():118347. PubMed ID: 38801914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shenlian extract improves atherosclerosis by relieving adventitial inflammation.
    Han S; Nie C; Wang C; Song M; Li J; Cui X; Yang Q; Li Y; Chen Y; Li Q; Cai W; Weng X; Wang Y; Zhu X
    J Ethnopharmacol; 2024 Feb; 320():117339. PubMed ID: 37866468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury.
    Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J
    Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated network pharmacology to investigate the mechanism of Salvia miltiorrhiza Bunge in the treatment of myocardial infarction.
    Huang X; Zhang M; Song Y; Sun B; Lin L; Song X; Li C
    J Cell Mol Med; 2023 Nov; 27(22):3514-3525. PubMed ID: 37643320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating network pharmacology and experimental evidence to decipher the cardioprotective mechanism of Yiqihuoxue decoction in rats after myocardial infarction.
    Li FH; Guo SW; Zhan TW; Mo HR; Chen X; Wang H; Wei LL; Feng PF; Wu JG; Li P
    J Ethnopharmacol; 2021 Oct; 279():114062. PubMed ID: 33771641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
    Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
    J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the mechanism of action of Radix Angelica sinensis (Oliv.) Diels and Radix Astragalus mongholicus Bunge ultrafiltration extract on radiation-induced myocardial fibrosis based on network pharmacology and experimental research.
    Ren C; Wang L; Li X; Tang Y; Zhi X; Zhuang M; Chen Q; Gao X; Lv X; Wang C; Wu X; Liu K; Zhao X; Li Y
    Eur J Pharm Sci; 2024 Aug; 199():106794. PubMed ID: 38788908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanism of Dalbergia cochinchinensis heartwood in regulation of energy metabolism to treat myocardial ischemia based on network pharmacology and experimental validation].
    Cheng LH; Chen LY; Shou BY; Luo YY; Cui YR; Liu RH
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6696-6708. PubMed ID: 36604920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Network Pharmacology and an Experimental Model to Investigate the Effect of Zhenwu Decoction on Doxorubicin-Induced Heart Failure.
    Hu Y; Qu H; Zhou H
    Comb Chem High Throughput Screen; 2023; 26(14):2502-2516. PubMed ID: 37056062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
    Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
    J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury.
    Xing N; Qin J; Ren D; Du Q; Li Y; Mi J; Zhang F; Ai L; Zhang S; Zhang Y; Wang S
    J Ethnopharmacol; 2023 Oct; 314():116572. PubMed ID: 37201662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L.
    Wang Y; Shi Y; Zou J; Zhang X; Liang Y; Tai J; Cui C; Wang M; Guo D
    BMC Complement Med Ther; 2020 Nov; 20(1):351. PubMed ID: 33213432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shenlian extract protects against ultrafine particulate matter-aggravated myocardial ischemic injury by inhibiting inflammation response via the activation of NLRP3 inflammasomes.
    Qu S; Li K; Yang T; Yang Y; Zheng Z; Liu H; Wang X; Zhang Y; Deng S; Zhu X; Chen L; Li Y
    Environ Toxicol; 2021 Jul; 36(7):1349-1361. PubMed ID: 33729688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia-reperfusion injury.
    Yang Y; Chen T; Liu J; Chen S; Cai R; Wu L; Hu J; Lin Q; Qi X; Liu Z; Cheng Y
    Pharm Biol; 2022 Dec; 60(1):255-273. PubMed ID: 35148221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shenlian extract decreases mitochondrial autophagy to regulate mitochondrial function in microvascular to alleviate coronary artery no-reflow.
    Li JJ; Wang YJ; Wang CM; Li YJ; Yang Q; Cai WY; Chen Y; Zhu XX
    Phytother Res; 2023 May; 37(5):1864-1882. PubMed ID: 36740450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.